Paychex, Inc. financials

  1. Home
  2. Financials
  3. PAYX
PAYX CIK 0000723531

Source: EDGAR filings · Built 2026-06-02T03:47:17Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.71B 1.74B 1.56B 1.46B 1.14B 1.31B
EBITDA 2.42B 2.35B 2.21B 2.03B 1.65B 1.67B
Working Capital 1.96B 1.94B 1.72B 1.31B 1.23B 1.04B
Net Debt 3.42B -583.40M -336.00M 536.30M -69.20M 30.80M
Gross Margin 71.53% 71.17% 70.39% 70.22% 68.20% 67.60%
Operating Margin 40.81% 42.36% 41.43% 40.40% 36.54% 36.94%
Net Margin 30.63% 32.94% 31.73% 30.58% 27.45% 27.77%
Return on Equity (ROE) 40.15% 44.47% 44.58% 45.14% 37.23% 39.48%
Return on Assets (ROA) 10.01% 16.28% 14.77% 14.46% 11.89% 12.84%
Current Ratio 1.28× 1.37× 1.30× 1.25× 1.25× 1.23×
Debt-to-Equity 1.22× 0.23× 0.25× 0.29× 0.31× 0.34×
Effective Tax Rate 23.83% 23.79% 23.97% 23.67% 23.48% 23.59%
Cash Conversion Ratio 1.15× 1.12× 1.10× 1.14× 1.15× 1.31×
Accruals Ratio -0.01× -0.02× -0.01× -0.02× -0.02× -0.04×
SBC % of Revenue 2.07% 1.19% 1.28% 1.16% 1.31% 1.20%
CapEx Coverage 9.91× 11.76× 11.93× 11.88× 10.64× 11.35×
Free Cash Flow Per Share $4.72 $4.80 $4.31 $4.01 $3.15 $3.64

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 34.48× 25.73× 24.40× 32.25× 33.38× 23.78×
P/FCF 33.45× 25.06× 24.32× 30.88× 32.07× 19.86×
FCF Yield 2.99% 3.99% 4.11% 3.24% 3.12% 5.04%
EV / EBITDA 24.96× 18.16× 16.97× 22.20× 21.98× 15.55×
P/S 10.52× 8.43× 7.71× 9.79× 9.10× 6.56×
P/B 13.79× 11.38× 10.83× 14.45× 12.34× 9.32×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 5.41B 5.13B 4.91B 4.55B 4.00B 3.95B
Revenues 5.57B 5.28B 5.01B 4.61B 4.06B 4.04B
Cost of Revenue 1.54B 1.48B 1.45B 1.36B 1.27B 1.28B
Selling, General and Administrative Expense 1.82B 1.62B 1.52B 1.42B 1.32B 1.30B
Operating Income (Loss) 2.21B 2.17B 2.03B 1.84B 1.46B 1.46B
Income Tax Expense (Benefit) 518.60M 527.60M 490.90M 431.80M 336.70M 339.00M
Earnings Per Share, Basic $4.60 $4.69 $4.32 $3.86 $3.05 $3.06
Weighted Average Number of Shares Outstanding, Basic 360.20M 360.30M 360.40M 360.60M 359.90M 358.50M
Earnings Per Share, Diluted $4.58 $4.67 $4.30 $3.84 $3.03 $3.04
Weighted Average Number of Shares Outstanding, Diluted 362.00M 362.10M 362.30M 363.10M 362.10M 361.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.63B 1.47B 1.22B 370.00M 995.20M 905.20M
Assets, Current 8.92B 7.25B 7.53B 6.58B 6.17B 5.46B
Assets 16.56B 10.38B 10.55B 9.64B 9.23B 8.55B
Long-term Debt 4.95B 798.60M 798.20M 797.70M 797.30M 796.80M
Liabilities, Current 6.96B 5.31B 5.81B 5.27B 4.94B 4.43B
Long-term Debt, Excluding Current Maturities 4.55B 798.60M 798.20M 797.70M 797.30M 796.80M
Liabilities 12.44B 6.58B 7.05B 6.55B 6.28B 5.77B
Stockholders' Equity Attributable to Parent 4.13B 3.80B 3.49B 3.09B 2.95B 2.78B
Common Stock, Shares, Outstanding 360.50M 360.10M 360.50M 359.90M 359.80M 358.80M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.90B 1.90B 1.71B 1.59B 1.26B 1.44B
Payments to Acquire Property, Plant, and Equipment 191.80M 161.40M 143.00M 133.80M 118.40M 127.00M
Net Cash Provided by (Used in) Investing Activities -3.36B -260.90M 211.70M -1.51B -460.60M 771.90M
Payments for Repurchase of Common Stock 104.50M 169.20M 0 145.20M 155.70M 171.90M
Net Cash Provided by (Used in) Financing Activities 2.29B -1.87B -711.40M -979.30M -636.40M -1.49B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PAYX CIK 0000723531), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ICUI

ICU MEDICAL INC/DE

RUN

Sunrun Inc.

BCPC

Balchem Corp